Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Muraro

Showing results (151-160 of 234) with videos related to

Pageof 24
Sort By:
Allergy|February 12, 2026
Correspondence: First Peanut (Arachis hypogaea) Allergen Oral Immunotherapy Product Out of Sale-A Major Drawback for Food Allergy Immunotherapy?S Arasi, F Bärhold, M Alvaro-Lozano, et al.
Brain : a Journal of Neurology|July 19, 2013
Non-myeloablative autologous haematopoietic stem cell transplantation expands regulatory cells and depletes IL-17 producing mucosal-associated invariant T cells in multiple sclerosisSofia V Abrahamsson, Daniela F Angelini, Amy N Dubinsky, et al.
Multiple Sclerosis and Related Disorders|June 3, 2025
Approach to JCV testing with natalizumab biosimilar: a UK consensus statementRuth Dobson, Tarunya Arun, James Varley, et al.
The Review of Scientific Instruments|December 3, 2016
Performance of the prototype LaBr<sub>3</sub> spectrometer developed for the JET gamma-ray camera upgradeD Rigamonti, A Muraro, M Nocente, et al.
Frontiers in Neurology|December 28, 2020
Rehabilitation Before and After Autologous Haematopoietic Stem Cell Transplantation (AHSCT) for Patients With Multiple Sclerosis (MS): Consensus Guidelines and Recommendations for Best Clinical Practice on Behalf of the Autoimmune Diseases Working Party, Nurses Group, and Patient Advocacy Committee of the European Society for Blood and Marrow Transplantation (EBMT)Fiona Roberts, Helen Hobbs, Helen Jessop, et al.
Trials|May 11, 2019
MEsenchymal StEm cells for Multiple Sclerosis (MESEMS): a randomized, double blind, cross-over phase I/II clinical trial with autologous mesenchymal stem cells for the therapy of multiple sclerosisAntonio Uccelli, Alice Laroni, Lou Brundin, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|March 20, 2013
Testing children for allergies: why, how, who and when: an updated statement of the European Academy of Allergy and Clinical Immunology (EAACI) Section on Pediatrics and the EAACI-Clemens von Pirquet FoundationP A Eigenmann, M Atanaskovic-Markovic, J O'B Hourihane, et al.
Bone Marrow Transplantation|September 28, 2019
Autologous haematopoietic stem cell transplantation and other cellular therapy in multiple sclerosis and immune-mediated neurological diseases: updated guidelines and recommendations from the EBMT Autoimmune Diseases Working Party (ADWP) and the Joint Accreditation Committee of EBMT and ISCT (JACIE)Basil Sharrack, Riccardo Saccardi, Tobias Alexander, et al.
Rheumatology (Oxford, England)|December 7, 2021
Long-term follow-up after lymphodepleting autologous haematopoietic cell transplantation for treatment-resistant systemic lupus erythematosusSencer Goklemez, Sarfaraz Hasni, Frances T Hakim, et al.
Allergy|March 18, 2017
Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis - A EUFOREA-ARIA-EPOS-AIRWAYS ICP statementP W Hellings, W J Fokkens, C Bachert, et al.
Pageof 24

Showing results (151-160 of 234) with videos related to

Sort By:
Pageof 24
Allergy|February 12, 2026
Correspondence: First Peanut (Arachis hypogaea) Allergen Oral Immunotherapy Product Out of Sale-A Major Drawback for Food Allergy Immunotherapy?S Arasi, F Bärhold, M Alvaro-Lozano, et al.
Brain : a Journal of Neurology|July 19, 2013
Non-myeloablative autologous haematopoietic stem cell transplantation expands regulatory cells and depletes IL-17 producing mucosal-associated invariant T cells in multiple sclerosisSofia V Abrahamsson, Daniela F Angelini, Amy N Dubinsky, et al.
Multiple Sclerosis and Related Disorders|June 3, 2025
Approach to JCV testing with natalizumab biosimilar: a UK consensus statementRuth Dobson, Tarunya Arun, James Varley, et al.
The Review of Scientific Instruments|December 3, 2016
Performance of the prototype LaBr<sub>3</sub> spectrometer developed for the JET gamma-ray camera upgradeD Rigamonti, A Muraro, M Nocente, et al.
Frontiers in Neurology|December 28, 2020
Rehabilitation Before and After Autologous Haematopoietic Stem Cell Transplantation (AHSCT) for Patients With Multiple Sclerosis (MS): Consensus Guidelines and Recommendations for Best Clinical Practice on Behalf of the Autoimmune Diseases Working Party, Nurses Group, and Patient Advocacy Committee of the European Society for Blood and Marrow Transplantation (EBMT)Fiona Roberts, Helen Hobbs, Helen Jessop, et al.
Trials|May 11, 2019
MEsenchymal StEm cells for Multiple Sclerosis (MESEMS): a randomized, double blind, cross-over phase I/II clinical trial with autologous mesenchymal stem cells for the therapy of multiple sclerosisAntonio Uccelli, Alice Laroni, Lou Brundin, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|March 20, 2013
Testing children for allergies: why, how, who and when: an updated statement of the European Academy of Allergy and Clinical Immunology (EAACI) Section on Pediatrics and the EAACI-Clemens von Pirquet FoundationP A Eigenmann, M Atanaskovic-Markovic, J O'B Hourihane, et al.
Bone Marrow Transplantation|September 28, 2019
Autologous haematopoietic stem cell transplantation and other cellular therapy in multiple sclerosis and immune-mediated neurological diseases: updated guidelines and recommendations from the EBMT Autoimmune Diseases Working Party (ADWP) and the Joint Accreditation Committee of EBMT and ISCT (JACIE)Basil Sharrack, Riccardo Saccardi, Tobias Alexander, et al.
Rheumatology (Oxford, England)|December 7, 2021
Long-term follow-up after lymphodepleting autologous haematopoietic cell transplantation for treatment-resistant systemic lupus erythematosusSencer Goklemez, Sarfaraz Hasni, Frances T Hakim, et al.
Allergy|March 18, 2017
Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis - A EUFOREA-ARIA-EPOS-AIRWAYS ICP statementP W Hellings, W J Fokkens, C Bachert, et al.
Pageof 24